Iodobenzamide for in vivo exploration of central dopamine receptros: Evaluation in animal models of supersensitivity
- 31 December 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 47 (8) , 729-734
- https://doi.org/10.1016/0024-3205(90)90628-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonistBrain Research, 1988
- Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracersBrain Research, 1988
- Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using11C-N-methyl-spiperoneActa Neurologica Scandinavica, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986
- Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamidesJournal of Medicinal Chemistry, 1985
- []-N-: The radioligand of choice for pett studies of the dopamine receptor in human brainLife Sciences, 1985
- 76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptorsLife Sciences, 1984
- Imaging Dopamine Receptors in the Human Brain by Positron TomographyScience, 1983
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966